Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Genset (NasdaqNM:GENXY)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Reports
Recent Events
Aug 30Price hit new 52-week low ($1.08)
Location
24, rue Royal, 75008 Paris
France, France
Phone: (212) 815-2510
Fax: (212) 571-3050
Employees (last reported count): 500
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 32%
·Institutional: 26% (38% of float)
(46 institutions)
·Net Inst. Selling: 228.0K shares (+3.78%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Genset is an integrated genomics company. The Company's mission is to discover and license genomics information relevant for the discovery, development and marketing of new therapeutics for common diseases. The Company has developed an original approach to the discovery of important genes, based on association studies in human populations. These studies are made possible by the Company's technology platform, which integrates key scientific tools that the Company has either invented or applied in novel ways. The Company's strategy is to focus its research efforts in the following fields: central nervous system diseases; metabolic disorders, and in particular obesity; and pharmacogenomics, which is the application of genomics technologies to the identification and analysis of genes involved in drug response.
More from Market Guide: Expanded Business Description

Financial Summary
Genset is a fully integrated genomics company engaged in assisting pharmaceutical companies in the discovery, development and marketing of their drugs through the discovery and analysis of common disease and drug response genes. For the six months ended 6/01, revenues decreased 44% to EUR9.8 million. Net loss totalled EUR29.4 million, up from EUR13.6 million. Results reflect decreased product sales, and EUR7.6 million in non-recurring charges.
More from Market Guide: Significant Developments

Officers

Position
Pascal Brandys, 41Chairman and CEO
John Varian, 41CFO
Daniel Cohen, M.D., Ph.D., 49Director and CGO
Marc Vasseur, Ph.D., 50Director and CBO
Philippe Rousseau, 29VP-Fin.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:GENXYAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Aug-2001
$1.08 
Recent Price$1.22 
52-Week High
on 1-Sep-2000
$29.625
Beta1.45 
Daily Volume (3-month avg)143.9K
Daily Volume (10-day avg)35.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-95.8%
52-Week Change
relative to S&P500
-94.4%
Share-Related Items
Market Capitalization$29.7M
Shares Outstanding24.3M
Float16.5M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.81 
Earnings (ttm)-$1.86 
Earnings (mrq)-$0.44 
Sales (ttm)$0.83 
Cash (mrq)$1.57 
Valuation Ratios
Price/Book (mrq)1.51 
Price/EarningsN/A 
Price/Sales (ttm)1.46 
Income Statements
Sales (ttm)$20.2M
EBITDA (ttm)-$45.8M
Income available to common (ttm)-$45.1M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-38.33%
Return on Equity (ttm)-107.96%
Financial Strength
Current Ratio (mrq)3.24 
Debt/Equity (mrq)2.82 
Total Cash (mrq)$38.3M
Short Interest
As of 8-Aug-2001
Shares Short36.0K
Percent of Float0.2%
Shares Short
(Prior Month)
28.0K
Short Ratio0.10 
Daily Volume346.0K
ADR Information
Shares/ADR0.333
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001);   dollar amounts based on an exchange rate of 1.1 Euro/Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.